Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 437-446
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.437
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.437
Figure 2 Receiver operating characteristic curves for the discrimination.
A: inflammatory bowel disease (IBD) and non-IBD group -irritable bowel syndrome and healthy controls; B: ulcerative colitis; C: Crohn's disease and non-IBD group. AUC: Area under curve.
- Citation: Manolakis AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, Tiaka EK, Oikonomou K, Valotassiou VJ, Potamianos SP. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease. World J Gastroenterol 2017; 23(3): 437-446
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/437.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.437